Incidence/Etiology
For the first occurrence of acute pancreatitis, the incidence in Western Europe is approximately 30 cases per 100,000 inhabitants per year.
75–80% of all cases in Western cultures are caused by biliary or alcohol toxicity, 10% are idiopathic.
10% show rare causes such as hypercalcemia, hypertriglyceridemia, tumor (cystic), pancreas divisum, dysfunction of the sphincter of Oddi, or are drug-induced or hereditary.
Clinical Presentation
Acute pancreatitis is characterized by abdominal pain accompanied by an increase in amylase and/or lipase to at least three times the normal level.
The course of acute pancreatitis varies from mild self-limiting (80%) to severe necrotizing form (20%).
The clinically severe form is associated with pancreatic tissue necrosis, a high rate of organ complications, and high mortality. Long-term pancreatic damage is expected in survivors.
The most severe clinical form shows early systemic organ complications with SIRS, sepsis, multi-organ failure, and very high mortality.
Since even in severe acute pancreatitis, very different clinical courses can be observed, the new Atlanta classification groups patients with regression of severe symptoms within the first week into an intermediate group.
Atlanta Classification
• Atlanta (1993)
2 groups: mild – severe
• Modified Atlanta (2012)
3 groups:
mild acute pancreatitis:
(¡) no organ failure
(¡¡) no local or systemic complications
moderately severe acute pancreatitis:
(¡) organ failure that resolves within 48 hours (transient organ failure) and/or
(¡¡) local or systemic complications without persistent organ failure
severe acute pancreatitis: persistent organ failure (> 48h)
(¡) single organ failure
(¡¡) multiple organ failure
Prognosis
Advances in the understanding of pathophysiology and modern, interdisciplinary intensive care management of life-threatening organ complications have significantly increased the success rate of therapy.
A proven infection of pancreatic necrosis is an absolute indication for surgery/intervention.
Through modern stage-appropriate therapy using available interventional and surgical methods in specialized centers, the mortality of necrotizing pancreatitis can be reduced to about 15–20%.
The reduction in mortality is primarily due to improved intensive care monitoring and therapy in the early phase, as well as the latest possible surgical intervention, since particularly surgery in the early phase of the disease (within the first 14 days) is associated with very high morbidity and mortality and should therefore be avoided whenever possible according to international consensus.
The quality of life for most patients is good after discharge from the hospital, and almost 90% of patients can return to work. Only with persistent alcohol consumption is there a mortality rate of about 10% in the following years, even after initially good recovery.
